Projecten per jaar
Persoonlijk profiel
Expertise
Molecular diagnostics in Hemato-Oncology
Reference lab coördinator for molecular Ig/TCR MRD testing in acute lymphoblastic leukemia and multiple myeloma
Vingerafdruk
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
-
FWOKN64: Moleculaire karakterisatie van transformerende gebeurtenissen in het 5T muis.
1/01/00 → 31/12/02
Project: Fundamenteel
-
FWOAL87: Evaluatie van minimale residuele ziekte in multiple myeloma en acute lymfoblastische leukemie.
1/01/97 → 31/12/97
Project: Fundamenteel
-
Comprehensive (Epi)Genetic Tumor Characterization and Disease Follow-Up in Multiple Myeloma Using Blood-Derived Cell-Free DNA
Heestermans, R., Olsen, C., Succari, J., Ameli, S., Janssen, T., De Becker, A., Vande Broek, I., Bakkus, M. H. C., Schots, R., De Bruyne, E. & Van Riet, I., 5 nov. 2024.Onderzoeksoutput: Poster
-
Development of a next-generation sequencing-based assay for NPM1 and FLT3-ITD mutation MRD detection.
Depreter, B., Kabongo, E. K., Linskens, E. & Bakkus, M. H. C., 7 nov. 2024. 1 blz.Onderzoeksoutput: Poster
-
Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study
Heestermans, R., De Brouwer, W., Maes, K., Vande Broek, I., Vaeyens, F., Olsen, C., Caljon, B., De Becker, A., Bakkus, M. H. C., Schots, R. & Van Riet, I., 7 okt. 2022, In: Cancers. 14, 19, 16 blz., 4901.Onderzoeksoutput: Article › peer review
Open Access4 Citaten (Scopus) -
Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators
Van der Straeten, J., De Brouwer, W., Kanjinga, E. K., Dresse, M-F., Fostier, K., Schots, R., Van Riet, I. & Bakkus, M., mei 2021, In: The Journal of Molecular Diagnostics. 23, 5, blz. 599-611 13 blz.Onderzoeksoutput: Article › peer review
Open Access5 Citaten (Scopus) -
Immunomagnetic enrichment of circulating tumor cells prior to tumor Ig specific qASO-PCR enhances the sensitivity of minimal residual disease detection in multiple myeloma
De Brouwer, W., Van der Straeten, J., Demanet, C., Schots, H., Bakkus, M. & Van Riet, I., 2018, blz. 29-29. 1 blz.Onderzoeksoutput: Poster
Activiteiten
-
Characterization of the evolving mutational landscape in multiple myeloma during disease progression using blood-derived cell free DNA: an explorative study
Robbe Heestermans (Speaker), Wouter De Brouwer (Contributor), Ken Maes (Contributor), Isabelle Vande Broek (Contributor), Freya Vaeyens (Contributor), Catharina Olsen (Contributor), Toon Janssen (Contributor), Ann De Becker (Contributor), Marleen Bakkus (Contributor), Henri Schots (Contributor) & Ivan Van Riet (Contributor)
3 feb. 2023Activiteit: Talk or presentation at a conference
-
Lab Secrets for Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS): Strategies to Leverage NGS-based minimal residual disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
Wouter De Brouwer (Invited speaker), Jona Van der Straeten (Contributor), Ivan Van Riet (Contributor) & Marleen Bakkus (Contributor)
24 feb. 2022Activiteit: Talk at a public lecture/debate
-
The best liquid biopsy for myeloma detection by immunoglobulin targeted NGS
Wouter De Brouwer (Speaker), Ivan Van Riet (Contributor), Robbe Heestermans (Contributor), Jona Van der Straeten (Contributor), Isabelle Vande Broek (Contributor), Marleen Bakkus (Contributor) & Henri Schots (Contributor)
4 feb. 2022Activiteit: Talk or presentation at a conference
-
EuroClonality Workshop: "Clonality assessment in pathology"
Marleen Bakkus (Participant)
11 feb. 2019 → 13 feb. 2019Activiteit: Participation in conference
-
34th General Annual Meeting of the Belgian Hematology Society
Marleen Bakkus (Participant) & Jona Van der Straeten (Participant)
1 feb. 2019 → 2 feb. 2019Activiteit: Participation in conference